CSIMarket Company Name, Ticker, Competitors, else..
 
Rock Creek Pharmaceuticals, Inc.  (RCPI)
 

Rock Creek Pharmaceuticals's Customers Performance

RCPI


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
RCPI's Source of Revenues

• List of RCPI Customers




for the same period Rock Creek Pharmaceuticals, Inc.

• List of RCPI Customers





Rock Creek Pharmaceuticals's Comment on Sales, Marketing and Customers



The Roskamp Institute is a private nonprofit medical research organization in Sarasota, Florida whose stated purpose is understanding causes of and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. Dr. Mullan, our Chief Executive Officer, is a co-founder of the Roskamp Institute and formerly served as the Chief Executive Officer of the Roskamp Institute. Dr. Mullan is also a member of the Board of Directors for the Roskamp Institute and provides consulting services from time to time.

We have entered into a Research and Royalty Agreement with an affiliate of the Roskamp Institute pursuant to which we were obligated to pay royalties of 5% of Anatabloc® sales (such royalties being equal to approximately. These royalties have been reclassified to discontinued operations in our consolidated statements of operations.

In 2014, we entered into a Master Services Agreement and a Royalty Agreement with the Roskamp Institute and SRQ Bio LLC, pursuant to which we engaged their research services on various projects, under terms and conditions as described in Task Orders (as defined in the Agreements). These projects relate to our ongoing drug development programs and the Developed Products or Services (as defined in the Agreements), arising from these projects, if successfully commercialized, may require Royalty payments from us of 5% of any proceeds received by us. To date no royalty payments have been paid or are payable under these current projects.













RCPI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Rock Creek Pharmaceuticals, Inc. 0.00 0.00 -11.15 5
SUBTOTAL 0.00 0.00 0.00 -

Sources: Rock Creek Pharmaceuticals, Inc.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Rock Creek Pharmaceuticals, Inc.’s corporate clients.
For your research, we’ve provided 9 tables on Rock Creek Pharmaceuticals, Inc. corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.